| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |